PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.46%
Revenue growth at 75-90% of META's 3.28%. Bill Ackman would push for innovation or market expansion to catch up.
3.04%
Gross profit growth under 50% of META's 7.88%. Michael Burry would be concerned about a severe competitive disadvantage.
-3.19%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-3.19%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-2.64%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-1.61%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-1.63%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.27%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.84%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-22.64%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-17.79%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
465.46%
10Y revenue/share CAGR under 50% of META's 1591.58%. Michael Burry would suspect a lasting competitive disadvantage.
181.73%
5Y revenue/share CAGR at 75-90% of META's 237.11%. Bill Ackman would encourage strategies to match competitor’s pace.
88.65%
3Y revenue/share CAGR similar to META's 81.46%. Walter Schloss would assume both companies experience comparable short-term cycles.
352.71%
10Y OCF/share CAGR under 50% of META's 3402.34%. Michael Burry would worry about a persistent underperformance in cash creation.
175.88%
5Y OCF/share CAGR 1.25-1.5x META's 148.09%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
62.16%
3Y OCF/share CAGR 1.25-1.5x META's 50.52%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
469.47%
Below 50% of META's 3059.73%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
377.49%
5Y net income/share CAGR above 1.5x META's 87.41%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
69.60%
Below 50% of META's 171.76%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
291.14%
10Y equity/share CAGR at 50-75% of META's 556.66%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
81.13%
5Y equity/share CAGR at 75-90% of META's 106.25%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
40.11%
3Y equity/share CAGR at 75-90% of META's 50.64%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.07%
AR growth well above META's 1.19%. Michael Burry fears inflated revenue or higher default risk in the near future.
44.63%
Inventory growth of 44.63% while META is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-0.54%
Negative asset growth while META invests at 3.39%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.82%
Under 50% of META's 2.85%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
1.08%
Debt shrinking faster vs. META's 14.33%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
7.92%
R&D growth drastically higher vs. META's 12.75%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
11.83%
SG&A growth well above META's 16.04%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.